Results 91 to 100 of about 101,157 (242)

Co‐Occurring Risk Factors for Tuberculosis Preventive Treatment Non‐Adherence Among People Living With HIV in Ethiopia: A Latent Class Analysis

Tropical Medicine &International Health, EarlyView.
ABSTRACT Objective Non‐adherence to tuberculosis preventive treatment (TPT) among people living with HIV (PLHIV) is a critical issue in Ethiopia and other Sub‐Saharan African countries, where both TB and HIV burdens are high. To reduce TPT non‐adherence among PLHIV, it is crucial to identify those at risk and implement targeted interventions. Therefore,
Edao Sinba Etu, Jet Fransen, Biftu Geda, Kemal Ahmed Kuti, Anteneh Fikrie, Mark Spigt   +5 more
wiley   +1 more source

Social Representations of Aids and of the Antiretroviral Therapy for People Living with HIV

Psicologia, 2008
The aim of this study was to characterize the social representation of Aids and Highly Active Antiretroviral Therapy (HAART) for people living with HIV that have adherence to treatment, users of the public health services of Florianópolis, Santa Catarina.
Tatiana de Lucena Torres, Brígido Vizeu Camargo   +1 more
doaj  

Antiretroviral resistance in HIV-infected Saudi children failing first-line highly active antiretroviral therapy

Annals of Saudi Medicine, 2012
BACKGROUND AND OBJECTIVES: The use of a potent combination of antiretroviral (ARV) drugs, so-called highly active ARV therapy (HAART), has dramatically improved the quality of life and overall survival of children with human immunodeficiency virus (HIV ...
Sami Hussain Al Hajjar, Husn Frayha, Sahar Althawadi   +2 more
doaj   +1 more source

Sexual and reproductive health and rights in anticipatory action for disasters

Disasters, Volume 50, Issue 3, July 2026.
Abstract An examination of the incorporation of sexual and reproductive health and rights (SRHR) in anticipatory action (AA) reveals the latter's potential to strengthen disaster response by addressing pre‐existing inequalities and marginalised needs.
Ellie Edmond Shimmin, Emmanuel Raju
wiley   +1 more source

Monitoring of highly active antiretroviral therapy in HIV infection

Current Opinion in Infectious Diseases, 2011
Patients on antiretroviral therapy (ART) in high-income countries have routine laboratory tests to monitor ART efficacy/toxicity. We review studies describing the outcomes and costs of different monitoring approaches, predominantly in low-income countries.CD4 cell counts, HIV RNA viral load and clinical events are frequently discordant; viral load ...
Walker, A, Gibb, D
openaire   +3 more sources

Short and long term retention in antiretroviral care in health facilities in rural Malawi and Zimbabwe. [PDF]

, 2012
Despite the successful scale-up of ART services over the past years, long term retention in ART care remains a major challenge, especially in high HIV prevalence and resource-limited settings.
A Boulle, A Kagee, AD Harries, AD Harries, AD Harries, AK Chan, AL Gifford, AP Hardon, D Ekouevi, D Swendeman, DW Krebs, DW Lowrance, E Losina, E Wouters, EH Geng, F Cellettti, F Shumbusho, Freya Rasschaert, GP Bisson, H Bussmann, H Tweya, JK Yu, JM Tassie, JS Stringer, L Ferradini, L Myer, LG Bekker, Lut Lynen, M Callaghan, M Egger, M Massaquoi, M McGuire, M Posse, Marcel Manzi, MP Fox, MW Brinkhof, Olivier Koole, P Braitstein, R Cohen, R Elema, R Zachariah, R Zachariah, Rony Zachariah, RP Dalal, RT Lester, RT Lester, S Rosen, S Rosen, S Thai, SD Lawn, SD Lawn, T Decroo, T Decroo, United Nations General Assembly, W Van Damme, W Van Damme, Wim Van Damme, Y Assefa   +57 more
core   +4 more sources

Nonavalent HPV vaccine to prevent recurrent anal or vulvar high‐grade squamous intraepithelial lesions (VIVA trial): A randomized, double‐blind, placebo‐controlled trial

International Journal of Cancer, Volume 158, Issue 11, Page 2983-2994, 1 June 2026.
What's new? Anal and vulvar high‐grade squamous intraepithelial lesions (HSILs) frequently recur following treatment. Additional genital and anal procedures, however, can be distressing for patients and are potentially disfiguring. This trial assessed whether the 9‐valent human papillomavirus (9vHPV) vaccine reduces HSIL recurrence risk or HPV ...
Helen C. Stankiewicz Karita, Amalia S. Magaret, David R. Doody, Jeffrey T. Schouten, Constance Mao, Warner K. Huh, Verena S. Grieco, Matthew A. Seymour, Dana Varon, Kelly H. Shrader, Long Fu Xi, Denise A. Galloway, Anna Wald, Margaret M. Madeleine   +13 more
wiley   +1 more source

Incidence, clinical presentation, and outcome of HIV-1-associated cryptococcal meningitis during the highly active antiretroviral therapy era: a nationwide cohort study

Clinical Epidemiology, 2017
Madeleine Touma,1 Line D Rasmussen,2 Raquel Martin-Iguacel,2 Frederik Neess Engsig,3 Nina Breinholt Stærke,4 Mette Stærkind,5 Niels Obel,1 Magnus Glindvad Ahlström1 1Department of Infectious Diseases, Rigshospitalet, Copenhagen ...
Touma M, Rasmussen LD, Martin-Iguacel R, Engsig FN, Stærke NB, Stærkind M, Obel N, Ahlström MG   +7 more
doaj  

Assessing the Efficacy of Highly Active Antiretroviral Therapy in the Brain

Brain Pathology, 2003
The devastating effects of HIV infection have been documented for the last 2 decades. Since the 1980s over 60 million people have been infected and at present 40 million people globally are living with HIV (72). HIV infects the central nervous system (CNS) early in the disease process.
Kandanearatchi, A, Williams, B P, Everall, I P   +2 more
openaire   +4 more sources

Public Health Achievements in Rwanda: A 21st Century Transformation

Public Health Challenges, Volume 5, Issue 2, June 2026.
This narrative review examines Rwanda's post‐2000 public health transformation using the WHO health system building blocks. It shows how strategic governance, universal health coverage via mutuelle de santé, community health workers, and digital health tools have driven substantial gains in maternal/child health, infectious disease control, and ...
Niyibizi Julius, Mugisha John, Nizeyimana Emmanuel   +2 more
wiley   +1 more source